share_log

BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024

SEC ·  Mar 27 20:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 393

Recommended